Abstract
Program Description:
As the demographics of oropharyngeal cancer change, so too will its management. Since these patients are often younger, have a better prognosis, and have presumably a longer life expectancy, we will discuss variations in treatment regimens. Using a case-based format and presentations from experts in the field, this miniseminar will review the management of the HPV-related cancer patient: molecular markers, chemotherapy and radiotherapy, the expanding role of surgery, neck management, and the potential for de-escalation of therapy. We will provide the practitioner with a practical, useful, and evidence based approach to the treatment of the HPV positive cancer patient.
Educational Objectives:
1) Recognize biomarkers for HPV-related head and neck cancer and understand their utility and limitations in clinical practice. 2) Develop a rational treatment plan for HPV-related head and neck cancer patients.
Get full access to this article
View all access options for this article.